ARCA biopharma, Inc. develops and commercializes genetically targeted therapies for cardiovascular diseases. The company was incorporated in 2004 and is headquartered in Westminster, Colorado. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 and Gencaro.
Market Cap | 30.261 Million | Shares Outstanding | 14.41 Million | Avg 30-day Volume | 25.683 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.55 |
Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -9.003 Million |
Price to Book Value | 0.7075 | Operating Margin | 0.0 | Enterprise Value | -12.174 Million |
Current Ratio | 32.94 | EPS Growth | 0.57 | Quick Ratio | 32.267 |
1 Yr BETA | 0.1851 | 52-week High/Low | 2.7 / 1.85 | Profit Margin | 0.0 |
Operating Cash Flow Growth | 53.9725 | Altman Z-Score | 5.5489 | Free Cash Flow to Firm | -7.183 Million |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
6,611 | 2022-12-15 | 1 | |
|
56,000 | 2022-12-15 | 1 | |
|
6,000 | 2022-12-15 | 1 | |
|
6,000 | 2022-12-15 | 1 | |
|
6,000 | 2022-12-15 | 1 | |
|
4,048,452 | 2022-12-15 | 3 | |
|
12,000 | 2022-12-15 | 2 | |
KEUER THOMAS A CHIEF OPERATING OFFICER |
|
40,730 | 2022-12-08 | 1 |
DEKKER C. JEFFREY CHIEF FINANCIAL OFFICER |
|
40,000 | 2022-12-08 | 1 |
|
2,580,452 | 2022-07-01 | 2 | |
|
2,580,452 | 2022-06-15 | 3 | |
|
2,594,952 | 2022-05-23 | 0 | |
|
1,822,651 | 2022-04-01 | 0 | |
BRISTOW MICHAEL R PRES. & CHIEF EXECUTIVE OFFIC |
|
99,808 | 2021-12-14 | 0 |
OZEROFF CHRISTOPHER DAVID S.V.P., GENERAL COUNSEL |
|
78,470 | 2021-12-14 | 0 |
SELBY BRIAN L. VP, FINANCE |
|
0 | 2020-12-21 | 0 |
|
No longer subject to file | 2018-02-26 | 0 | |
|
No longer subject to file | 2018-02-26 | 0 | |
|
No longer subject to file | 2018-02-26 | 0 | |
|
No longer subject to file | 2018-02-26 | 0 | |
|
No longer subject to file | 2018-02-26 | 0 | |
VENROCK HEALTHCARE CAPITAL PARTNERS LP VHCP CO-INVESTMENT HOLDINGS, LLC VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P. |
|
No longer subject to file | 2018-02-26 | 0 |
|
No longer subject to file | 2018-02-26 | 0 | |
|
No longer subject to file | 2018-02-26 | 0 | |
|
No longer subject to file | 2018-02-26 | 0 | |
|
No longer subject to file | 2018-02-26 | 0 | |
GROWTH EQUITY OPPORTUNITIES IV, LLC |
|
No longer subject to file | 2018-02-26 | 0 |
|
10,221,465 | 2015-06-16 | 0 | |
|
10,221,465 | 2015-06-16 | 0 | |
VENROCK HEALTHCARE CAPITAL PARTNERS LP VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P. VHCP CO-INVESTMENT HOLDINGS, LLC |
|
10,789,324 | 2015-06-16 | 0 |
|
No longer subject to file | 2015-01-14 | 0 | |
WHEELER PATRICK M CHIEF FINANCIAL OFFICER |
|
101,510 | 2014-09-18 | 0 |
|
0 | 2013-09-17 | 0 | |
|
1,579,542 | 2012-10-25 | 0 | |
|
1,579,542 | 2012-10-22 | 0 | |
|
0 | 2012-02-10 | 0 | |
|
0 | 2012-02-10 | 0 | |
|
1,337,612 | 2010-03-29 | 0 | |
|
0 | 2010-02-05 | 0 | |
|
0 | 2010-02-05 | 0 | |
|
0 | 2010-02-05 | 0 | |
|
No longer subject to file | 2009-07-17 | 0 | |
FALBERG KATHRYN E CFO AND COO |
|
0 | 2009-06-25 | 0 |
|
No longer subject to file | 2009-06-11 | 0 | |
JONES ANDREW E |
|
No longer subject to file | 2009-04-06 | 0 |
ST LAURENT RANDALL EVP COMMERCIAL OPERATIONS |
|
0 | 2009-01-27 | 0 |
BENDEKGEY E LEE CFO AND TREASURER |
|
1,502 | 2008-12-31 | 0 |
|
0 | 2008-06-04 | 0 | |
|
0 | 2008-06-04 | 0 | |
|
0 | 2008-06-04 | 0 | |
|
20,000 | 2007-05-31 | 0 | |
TITUS GARY CHIEF ACCT.OFFICER |
|
2,633 | 2006-08-30 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
ARCA BIOPHARMA INC ABIO | 2023-06-02 22:15:04 UTC | 3.5573 | 1.5027 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 21:45:04 UTC | 3.5573 | 1.5027 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 21:15:04 UTC | 3.5573 | 1.5027 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 20:45:03 UTC | 3.5573 | 1.5027 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 20:15:05 UTC | 3.5573 | 1.5027 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 19:45:04 UTC | 3.5573 | 1.5027 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 19:15:04 UTC | 3.5573 | 1.5027 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 18:45:04 UTC | 3.5573 | 1.5027 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 18:15:04 UTC | 3.5573 | 1.5027 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 17:45:03 UTC | 3.5573 | 1.5027 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 17:15:04 UTC | 3.5573 | 1.5027 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 16:45:03 UTC | 3.5673 | 1.5027 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 16:15:04 UTC | 3.5673 | 1.5027 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 15:45:04 UTC | 3.5673 | 1.5027 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 15:15:03 UTC | 3.5673 | 1.5027 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 14:45:04 UTC | 3.5673 | 1.5027 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 14:15:03 UTC | 3.5673 | 1.5027 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 13:45:03 UTC | 3.5657 | 1.5043 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 13:15:04 UTC | 3.5657 | 1.5043 | 750000 |
ARCA BIOPHARMA INC ABIO | 2023-06-02 12:45:03 UTC | 3.5657 | 1.5043 | 750000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|